Related Experiment Video
Updated: Aug 9, 2026
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Is mechanism-based pain treatment attainable? Clinical trial issues
1Pain Branch and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892-1258, USA. mm77k@nih.gov
Abstract:
Woolf et al have recently called for the development of a mechanism-based pain taxonomy to guide the individualization of treatment based on each patient's pain mechanisms. Although any scientific physician could endorse this ideal, small academic clinical trials so far have failed to identify obvious differences in the response of different pain symptoms in the same condition to various drugs. In contrast, there are clear differences in the analgesic responses of patient groups distinguished on the basis of etiology or tissue origin of pain, factors which tend to be associated with groups of mechanisms. The few tests to diagnose pain mechanisms remain too delicate, time-consuming, or uncomfortable for general clinical use. To understand how best to exploit new mechanistic insights to assign treatments, one must scrutinize the relative value of diagnostic classifications based on etiology, tissue, and individual patients' pain characteristics in large clinical trials. Research priorities should include developing simple methods for assessing pain mechanisms in the clinic and increasing the efficiency of pain assessment methods in clinical trials. I describe a collaborative research agenda for academic pain researchers and funding agencies, the pharmaceutical industry, and regulatory bodies.
Insights
Developing a mechanism-based pain taxonomy is crucial for personalized pain treatment. Current trials show limited success, highlighting the need for simpler clinical pain mechanism assessment methods.
Area of Science:
- Pain research
- Clinical pharmacology
- Translational medicine
Background:
- A mechanism-based pain taxonomy is proposed to individualize treatment.
- Small clinical trials have not differentiated drug responses based on specific pain symptoms within conditions.
- Patient groups based on pain etiology or tissue origin show distinct analgesic responses, often linked to underlying mechanisms.
Purpose of the Study:
- To evaluate the utility of diagnostic classifications (etiology, tissue, patient characteristics) in large trials for personalized pain treatment.
- To identify research priorities for advancing mechanism-based pain management.
Main Methods:
- Review of current clinical trial limitations in differentiating pain mechanisms.
- Analysis of the association between pain etiology/tissue origin and analgesic response.
- Discussion of the need for improved clinical diagnostic tools for pain mechanisms.
Main Results:
- Clear differences in analgesic responses exist between patient groups defined by pain etiology or tissue origin.
- Existing tests for pain mechanisms are often impractical for routine clinical use.
- Current small-scale trials lack the power to distinguish drug responses based on specific pain mechanisms.
Conclusions:
- Diagnostic classifications based on etiology or tissue origin are more informative than symptom-based ones for current clinical trials.
- Developing simple, efficient clinical methods for assessing pain mechanisms is a research priority.
- A collaborative research agenda is needed involving researchers, industry, and regulatory bodies to advance mechanism-based pain treatment.
